{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:59:19Z","timestamp":1793818759432,"version":"4.6.1"},"reference-count":52,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>Background: Congestive heart failure (CHF) management has proven devastating on morbidity, mortality, quality of life and also costly to health systems. Therapeutics for CHF have advanced and benefited greatly due to large multicentre randomised controlled trials and the evidence obtained from them. Management for chronic diseases and nonpharmaceutical therapies such as chronic disease self-management has lagged, and for CHF the evidence base has even been questioned. Methods: Perspective and non systematic mini review. Conclusions: Advancing translational research standards is important to achieve optimal cost effectiveness. Importantly is understanding evidence generation in medicine, identifying the primary roots for management and its translation.<\/jats:p>","DOI":"10.31083\/j.rcm2301037","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T09:29:35Z","timestamp":1642757375000},"source":"Crossref","is-referenced-by-count":3,"title":["Contextualising evidence based medicine in determining the key root for translational effectiveness for chronic disease self-management and heart failure"],"prefix":"10.31083","volume":"23","author":[{"given":"Pupalan","family":"Iyngkaran","sequence":"first","affiliation":[{"name":"Mitchell Institute for Education and Health Policy, Victoria University, 3000 Melbourne, Australia"},{"name":"School of Medicine Sydney, Werribee Mercy Sub School, University of Notre Dame, 3030 Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Hanna","sequence":"first","affiliation":[{"name":"Department of Public Health, Torrens University, 3000 Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Horowitz","sequence":"first","affiliation":[{"name":"Basil Hetzel Institute, University of Adelaide, 5011 Woodville South, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian P.","family":"de Courten","sequence":"first","affiliation":[{"name":"Mitchell Institute for Education and Health Policy, Victoria University, 3000 Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017; 136: e137\u2013161","DOI":"10.1161\/CIR.0000000000000509"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Society of Cardiology. 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013; 128: e240\u2013e327.","DOI":"10.1161\/CIR.0b013e31829e8776"},{"key":"ref4","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association. Circulation 2013; 127: e6\u2013245."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Curtis LH. Incidence and prevalence of heart failure in elderly persons, 1994\u20132003. Archives of Internal Medicine. 2008; 168: 418.","DOI":"10.1001\/archinternmed.2007.80"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Roger VL. Trends in heart failure incidence and survival in a community-based population. Journal of the American Medical Association. 2004; 292: 344.","DOI":"10.1001\/jama.292.3.344"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Differences in the incidence of congestive heart failure by ethnicity. Archives of Internal Medicine. 2008; 168: 2138.","DOI":"10.1001\/archinte.168.19.2138"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. Heart failure incidence and survival (from the atherosclerosis risk in communities study). The American Journal of Cardiology. 2008; 101: 1016\u20131022.","DOI":"10.1016\/j.amjcard.2007.11.061"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL. Moving from heart failure guidelines to clinical practice: gaps contributing to readmissions in patients with multiple comorbidities and older age. Cardiology. 2018; 12: 117954681880935.","DOI":"10.1177\/1179546818809358"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Heo S, Doering LV, Widener J, Moser DK. Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure. American Journal of Critical Care. 2008; 17: 124\u2013132.","DOI":"10.4037\/ajcc2008.17.2.124"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lesman-Leegte I, Jaarsma T, Coyne JC, Hillege HL, Van Veldhuisen DJ, Sanderman R. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. Journal of Cardiac Failure. 2009; 15: 17\u201323.","DOI":"10.1016\/j.cardfail.2008.09.006"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. New England Journal of Medicine. 2021; 385: 1451\u20131461.","DOI":"10.1056\/NEJMoa2107038"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Radder H. The philosophy of scientific experimentation: a review. Automated Experimentation. 2009; 1: 2.","DOI":"10.1186\/1759-4499-1-2"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Stone GW, Pocock SJ. Randomized trials, statistics, and clinical inference. Journal of the American College of Cardiology. 2010; 55: 428\u2013431.","DOI":"10.1016\/j.jacc.2009.06.066"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ting HH, Shojania KG, Montori VM, Bradley EH. Quality improvement. Circulation. 2009; 119: 1962\u20131974.","DOI":"10.1161\/CIRCULATIONAHA.108.768895"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Geboers H, van der Horst M, Mokkink H, van Montfort P, van den Bosch W, van den Hoogen H, et al. Setting up improvement projects in small scale primary care practices: feasibility of a model for continuous quality improvement. Quality and Safety in Health Care. 1999; 8: 36\u201342.","DOI":"10.1136\/qshc.8.1.36"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, Majoni W, Cass A, Sanders P, Ronco C, Brady S, et al. Northern territory perspectives on heart failure with comorbidities \u2013 understanding trial validity and exploring collaborative opportunities to broaden the evidence base. Heart, Lung and Circulation. 2015; 24: 536\u2013543.","DOI":"10.1016\/j.hlc.2014.12.007"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Geboers H, Mokkink H, Van Montfort P, Van Den Hoogen H, Van Den Bosch W, Grol R. Continuous quality improvement in small general medical practices: the attitudes of general practitioners and other practice staff. International Journal for Quality in Health Care. 2001; 13: 391\u2013397.","DOI":"10.1093\/intqhc\/13.5.391"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, R. Toukhsati S, Harris M, Connors C, Kangaharan N, Ilton M, et al. Self managing heart failure in remote australia - translating concepts into clinical practice. Current Cardiology Reviews. 2016; 12: 270\u2013284.","DOI":"10.2174\/1573403X12666160703183001"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Nieuwlaat R, Schwalm J, Khatib R, Yusuf S. Why are we failing to implement effective therapies in cardiovascular disease? European Heart Journal. 2013; 34: 1262\u20131269.","DOI":"10.1093\/eurheartj\/ehs481"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, Liew D, McDonald P, C. Thomas M, Reid C, Chew D, et al. Phase 4 studies in heart failure - what is done and what is needed? Current Cardiology Reviews. 2016; 12: 216\u2013230.","DOI":"10.2174\/1573403X12666160606121458"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Geboers H, van der Horst M, Mokkink H, van Montfort P, van den Bosch W, van den Hoogen H, et al. Setting up improvement projects in small scale primary care practices: feasibility of a model for continuous quality improvement. Quality and Safety in Health Care. 1999; 8: 36\u201342.","DOI":"10.1136\/qshc.8.1.36"},{"key":"ref24","unstructured":"Shojania KG, McDonald KM, Wachter RM, Owens DK. Closing the quality gap: a critical analysis of quality improvement strategies. Agency for healthcare research and quality publication No. 04-0051-1. 2004. Available at: http:\/\/www.ahrq.gov\/downloads\/pub\/evidence\/pdf\/qualgap1\/qualgap1.pdf (Accessed: 6 July 2021)."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Iyngkaran P, Liew D, McDonald P, C. Thomas M, Reid C, Chew D, et al. Phase 4 studies in heart failure - what is done and what is needed? Current Cardiology Reviews. 2016; 12: 216\u2013230.","DOI":"10.2174\/1573403X12666160606121458"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, et al. Future directions for cardiovascular disease comparative effectiveness research. Journal of the American College of Cardiology. 2012; 60: 569\u2013580.","DOI":"10.1016\/j.jacc.2011.12.057"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Gitt AK, Bueno H, Danchin N, Fox K, Hochadel M, Kearney P, et al. The role of cardiac registries in evidence-based medicine. European Heart Journal. 2010; 31: 525\u2013529.","DOI":"10.1093\/eurheartj\/ehp596"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Grol R, Dalhuijsen J, Thomas S, Veld CI\u2019, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. British Medical Journal. 1998; 317: 858\u2013861.","DOI":"10.1136\/bmj.317.7162.858"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, et al; Influence of a performance-improvement initiative on quality of care for hospitalized patients with heart failure: Results of the organized program to initiate lifesaving treatment in hospitalized patients heart failure (OPTIMIZE-HF). Archives of Internal Medicine.2007; 167: 1493\u20131502.","DOI":"10.1001\/archinte.167.14.1493"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal. 2008; 337: a1655.","DOI":"10.1136\/bmj.a1655"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Craig P, Dieppe P, MacItyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council Guidance. British Medical Journal. 2008; 337: a1655.","DOI":"10.1136\/bmj.a1655"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Sheridan DJ, Julian DG. Achievements and limitations of evidence-based medicine. Journal of the American College of Cardiology. 2016; 68: 204\u2013213.","DOI":"10.1016\/j.jacc.2016.03.600"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. Journal of the American Medical Association. 1992; 268: 2420\u20132425.","DOI":"10.1001\/jama.268.17.2420"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Loughlin M, Bluhm R, Buetow S, Upshur REG, Goldenberg MJ, Borgerson K, et al. Reason and value: making reasoning fit for practice. Journal of Evaluation in Clinical Practice. 2012; 18: 929\u2013937.","DOI":"10.1111\/j.1365-2753.2012.01896.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ghali JK, Massie BM, Mann DL, Rich MW. Heart failure guidelines, performance measures, and the practice of medicine. Journal of the American College of Cardiology. 2010; 56: 2077\u20132080.","DOI":"10.1016\/j.jacc.2010.07.013"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Bonow RO, Bennett S, Casey DE, Ganiats TG, Hlatky MA, konstam ma, et al. ACC\/AHA clinical performance measures for adults with chronic heart failure. Journal of the American College of Cardiology. 2005; 46: 1144\u20131178.","DOI":"10.1016\/j.jacc.2005.07.012"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Kersten JR. A recipe for perioperative cardioprotection. Circulation. 2012; 126: 2671\u20132673.","DOI":"10.1161\/CIRCULATIONAHA.112.147785"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Lionetti V, Barile L. Perioperative cardioprotection: back to bedside. Minerva Anestesiol. 2020; 86: 445\u2013454.","DOI":"10.23736\/S0375-9393.19.13848-5"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Agrimi J, Baroni C, Anakor E, Lionetti V. Perioperative Heart-Brain Axis Protection in Obese Surgical Patients: The Nutrigenomic Approach. Current Medicinal Chemistry. 2020; 27: 258\u2013281.","DOI":"10.2174\/0929867325666181015145225"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines? PLoS Medicine. 2007; 4: e250.","DOI":"10.1371\/journal.pmed.0040250"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength or recommendations. British Medical Journal. 2008; 336: 924\u2013926.","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Smith SC. Risk-Reduction therapy: the challenge to change. Circulation. 1996; 93: 2205\u20132211.","DOI":"10.1161\/01.CIR.93.12.2205"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"DeMaria AN. Clinical trials and clinical judgment. Journal of the American College of Cardiology. 2008; 51: 1120\u20131122.","DOI":"10.1016\/j.jacc.2008.02.030"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Clark AM, Savard LA, Thompson DR. What is the strength of evidence for heart failure disease-management programs? Journal of the American College of Cardiology. 2009; 54: 397\u2013401.","DOI":"10.1016\/j.jacc.2009.04.051"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure coordinating study evaluating outcomes of advising and counseling in heart failure (COACH). Archives of Internal Medicine. 2008;168: 316\u2013324.","DOI":"10.1001\/archinternmed.2007.83"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Nucifora G, Albanese MC, De Biaggio P, Caliandro D, Gregori D, Goss P, et al. Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management program. Journal of Cardiovascular Medicine. 2006; 7: 614\u2013622.","DOI":"10.2459\/01.JCM.0000237910.34000.58"},{"key":"ref47","unstructured":"Smith B, Forkner E, Zaslow B, Krasuski RA, Stajduhar K, Kwan M, et al. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community dwelling patients. The American Journal of Managed Care. 2005; 11: 701\u2013713."},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Nguyen V, Ducharme A, White M, Racine N, O\u2019Meara E, Zhang B, et al. Lack of long-term benefits of a 6-month heart failure disease management program. Journal of Cardiac Failure. 2007; 13: 287\u2013293.","DOI":"10.1016\/j.cardfail.2007.01.002"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits from community pharmacists for patients with heart failure: heartmed randomised controlled trial. British Medical Journal. 2007; 334: 1098.","DOI":"10.1136\/bmj.39164.568183.AE"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Ledwidge M, Ryan E, O\u2019Loughlin C, Ryder M, Travers B, Kieran E, et al. Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs. European Journal of Heart Failure. 2005; 7: 385\u2013391.","DOI":"10.1016\/j.ejheart.2004.10.022"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine. 2008; 148: 295.","DOI":"10.7326\/0003-4819-148-4-200802190-00008"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. British Medical Journal. 2007; 334: 455\u2013459.","DOI":"10.1136\/bmj.39108.379965.BE"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/1\/10.31083\/j.rcm2301037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T17:35:58Z","timestamp":1732728958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/23\/1\/10.31083\/j.rcm2301037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S1530-6550(22)00324-6"],"URL":"https:\/\/doi.org\/10.31083\/j.rcm2301037","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"article-number":"37"}}